Increased Prevalence of Alloimmunization in Sickle Cell Disease? Should We Restore Blood Donation in French Guiana?
Open Access
- 11 June 2021
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Medicine
Abstract
Patients with sickle cell disease often undergo frequent blood transfusions. This increases their exposure to red blood cell alloantigens of donor units, thus making it more likely that they produce alloantibodies. This cross-sectional study aimed to describe the prevalence of allo-immunization in patients with sickle cell disease who were monitored at Cayenne Hospital in 2016. Of the 451 patients recruited during the study period, 238 (52.8%) were female. There were 262 (58.1%) homozygous sickle cell and 151 (33.5%) compound heterozygous sickle cell patients. The median age of the participants was 23.09 years (range, 0.5–68). We noted different red blood cell extended phenotypes: -in the Duffy system, the Fya- Fyb–profile was found in 299 patients (66%);—for the Kidd system, the most represented profile was Jka+ Jkb-, with 213 patients (47%). The Jka antigen was present in 355 patients;—in the MNS system, the S-s+ profile was found in 297 patients (66%);—the Lea antigen of the Lewis system was absent in 319 patients. The most frequent Rh phenotype in our patients was D+ C- E- c+ e+ K-, representing 51% of the patients. A total of 6,834 transfused packed red blood cell units were recorded. Sixty-eight patients (23%; 95% confidence interval, 20–25%) had detectable RBC alloantibodies. In multivariate logistic regression, only the mean number of single transfusions was statistically higher for the alloimmunized patients (p < 0.04). Thirteen (19%) of the patients with alloimmunization developed a delayed hemolytic transfusion reaction, thus representing 4.4% of the total number of transfused patients. Whether differences between donors from France vs. recipients from French Guiana could explain this high prevalence of alloimmunization to be examined. In conclusion, careful transfusion strategies for patients with RBC alloantibodies should allow further reduction of the rate of alloimmunization.This publication has 41 references indexed in Scilit:
- Allo-immunisation anti-érythrocytaireTransfusion Clinique et Biologique, 2012
- Transfusion of fresh murine red blood cells reverses adverse effects of older stored red blood cellsTransfusion, 2011
- Delayed hemolytic transfusion reaction in children with sickle cell diseaseHaematologica, 2011
- Red blood cell alloantibodies after transfusion: factors influencing incidence and specificityTransfusion, 2005
- Risk factors for alloimmunization by patients with sickle cell diseaseBrazilian Journal of Medical and Biological Research, 2005
- Delayed Hemolytic Transfusion Reaction/Hyperhemolysis Syndrome in Children With Sickle Cell DiseasePEDIATRICS, 2003
- Particularités immunohématologiques dans les populations africaines et antillaises. Implications transfusionnellesTransfusion Clinique et Biologique, 2003
- Red cell antibodies in patients with homozygous sickle cell disease: a comparison of patients in Jamaica and the United KingdomBritish Journal of Haematology, 2001
- Red blood cell alloimmunization in sickle cell disease: The influence of racial and antigenic pattern differences between donors and recipients in BrazilAmerican Journal of Hematology, 1996
- Alloimmunization in Sickle Cell Anemia and Transfusion of Racially Unmatched BloodThe New England Journal of Medicine, 1990